<div id="readability-page-1"><div><p>Certain A Shares of Cofoe Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 26-OCT-2025. These A Shares will be under lockup for 1472 days starting from 15-OCT-2021 to 26-OCT-2025.</p><p>  Details:<br/> Holding shareholder Changsha Xiezihao Medical Investments Co., Ltd., actual controllers Zhang Min, Nie Juan and enterprise under control of actual controllers, Changsha Keyuan Tongchuang Enterprise Management Center (Limited Partnership) that within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.</p><p>  Actual controllers, Zhang Min, Nie Juan, member of the board of directors, member of senior management with shareholding Zhang Zhiming that If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months and during the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company.</p><p>  Actual controllers Zhang Min, Nie Juan, member of the board of directors, member of senior management with shareholding, Zhang Zhiming, member of the board of directors with indirect shareholding Fang Shengshi and member of supervisory board with indirect shareholding Zhou Xiaojun that during the term of office as the company?s director, member of supervisory board, senior management personnel, the number of shares in the company transferred each year shall not exceed 25% of the total shares held in the company.</p><p>Member of the board of directors, member of senior management with shareholding Zhang Zhiming and Shareholders Ningbo Huaige Gongxin Equity Investment Partnership Enterprise (Limited Partnership); Guangzhou Danlu Venture Capital investment Fund Partnership Enterprise (LP); Xiangtan Chanxing Dingxin Private Equity Fund Enterprise (Limited Partnership); Hunan Cultural Tourism Investment Fund Enterprise (Limited Partnership); Changsha Yuhua Economic Development Dingxin Private Equity Fund Partnership Enterprise (Limited Partnership); Hunan Pofu Cultural Industry Investment Fund Enterprise (L.P.); Hunan Yanjin Puzi Holding Co., Ltd.; Hu Hongxia that within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.</p></div></div>

可孚醫療

<p>可孚醫療科技有限公司的部分 A 股在鎖定協議下，直到 2025 年 10 月 26 日，鎖定期為 1472 天，從 2021 年 10 月 15 日開始。包括長沙謝子豪醫療投資有限公司及實際控制人張敏和聶娟在內的股東，無法轉讓在此次發行前持有的股份。如果在上市後 6 個月內，股價連續 20 個交易日低於發行價，鎖定期將延長 6 個月。此外，董事和高級管理人員在任期內每年只能轉讓最多 25% 的股份</p>

可孚醫療科技股份有限公司的部分 A 股受到鎖定協議的限制，該協議將於2025年10月26日到期